Allowing today’s children and adolescents to become tomorrow’s adult role models Our Paediatric Research Hub allows us to promote research in the fields of paediatrics and adolescence. In doing so, it highlights the centre’s vast expertise while uniting efforts and capabilities in order to undertake global change initiatives that allow us to achieve the objectives agreed upon by the entire community of professionals who participate in paediatric and adolescence research at the Vall d'Hebron Campus. The Hub in figures 30 30 Of all the VHIR’s groups participate in paediatric research 5 5 Research groups focusing exclusively on paediatrics 26 26 PIs focusing exclusively on paediatrics 353 353 Publications 3,205 3K Impact factor (total) 8 8 Impact Factor (average) 58 58 % publications Q1 167 167 Ongoing paediatric clinical trials 71 71 Ongoing competitive paediatric projects From research to healthcare Mission: To promote, develop and transfer the paediatric research work undertaken at Vall d'Hebron University Hospital. Through excellence in our research work, we improve the health and quality of life of children and adolescents. Vision: We want Vall d'Hebron’s paediatric research work to become a global benchmark which has a positive impact on the health and quality of life of paediatric patients and society in general. Strategic lines Pediatric clinical trials As leaders in research, Vall d'Hebron Research Institute are involved in many clinical trials to children and adolescents. In this list you will be able to consult the pediatric clinical trials in which they are working, as well as the phase in which it is and if there has active recruitment. See clinical trials Organization chart Documentation of strategic lines Organization and structure Clinical Trials and Advanced Therapies Training, mentoring and research promotion Innovation and knowledge transfer Collaboration, reference networks and fundraising Active patients participation Today Related news Renal Pathophysiology and Pediatric Nephrology awarded the best oral communication by AENP "Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work. Significant advancements and a fifteen-month extension for the RBDCOV Project So far, 240 volunteers have been recruited within all the centres set to join adolescents’ clinical trial (named HH3) to test the efficacy, tolerability, and safety of the BIMERVAX® COVID-19 vaccine in adolescents aged 12 to 17. Genetic basis of ADHD and autism spectrum disorder impacts on school performance These results reinforce the need for more individualized attention to address educational needs from an early stage. See more Do you want to collaborate with us? With your help we can increase knowledge of the different parologies that affect children and adolescents, improve diagnosis and discover new therapeutic approaches that have an impact on the quality of life of patients and their families. More information